1 8-24 Aza-motono, Miyamoto, Numazu-shi, Shizuoka 410-03, Japan (Received for publication June 4, 1987) Ubenimex is a low molecular irnmunomodifier exhibiting antitumor and antimicrobial activities through activation of host defense mechanisms1~4). Previously, we reported that forphenicinol which is also a low molecular weight immunomodifier5) stimulated inducer-elicited production of cytokines such as tumor necrosis factor (TNF) and interferons (IFN)6>7). The effect of ubenimexon immuneresponse in mice is different from that of forphenicinol. As for the effect on cytokine production, ubenimex induces interleukin 1 (IL-1) and enhances the concanavalin A (Con A)-induced production of . However, the effect of ubenimex on IFN production has not been known. In this paper, we report the results of the studies on the effect of ubenimex on IFN production in mice and discuss the difference in the effects of ubenimex and forphenicinol. ICR mice were purchased from Shizuoka Laboratory Animal Center (Shizuoka, Japan) and maintained in a barrier system. Single cell suspension of splenocytes was obtained by mechanically dispersing spleens. Cells were cultured in RPMI1640 medium supplemented with 10% calf serum at 37°C. Ubenimex was synthesized by Nippon Kayaku Co., Ltd. IFN assay was performed by means of inhibition of nucleic acid synthesis using mouse LY cells and vesicular stomatitis virus (VSV), and IFN activity was expressed as an international unit (IU)6). In the case of lipopolysaccharide (LPS, Escherichia coli 0111, Difco Lab., Detroit, MI, U.S.A.)-induced IFN production, though LPS might exist in serum samples, IFN activity in 261 sera was assayed without removing LPS from the sera because LPS did not affect the LY cells at a concentration up to 100 jug/ml. Moreover, the sera taken from mice injected with LPS contain TNF as well as IFN. By using TNFresistant LY cells, the interfering effect of TNF on IFN assay was excluded7}. To determine whether ubenimex was an IFN inducer or not, ICR mice were orally administered 1 or 10mg/kg ubenimex and bled 2, 4, or 24 hours after the administration. IFN activity in sera was determined. IFN activity was not detected in any sera taken from these mice (<10 IU/ml). Although ubenimex has a mitogenic activity against T cells8>9), spleen cells exposed to ubenimex at 1 to 100 /^g/ml for 24 or 48 hours did not produce IFN into the culture medium. However, when spleen cells of 1 x107 cells/ml were cultured in the mediumcontaining 20 jug/ml Con A (type IV, Sigma Chemical Co., St. Louis, MO, U.S.A.) for 24 hours they produced 659 lU/ml of IFN (Table 1) . Ubenimex added to the culture enhanced the production at a wideconcentrationrange. The effect of ubenimex administration on the IFN production in mice injected with IFN inducers was examined. ICR mice («=3) were sensitized by iv injection with 107 BCG cells (Japan BCGManufacturing Co., Tokyo, Japan) on day 0 and were given ubenimexorally once a daydailyfor 4 days from day 10 to 13. On day 14, they were injected intravenously with 107 BCG cells or 50jug of LPS. As shown in Spleen cells (1 x107 cells/ml) were exposed to ubenimex in the presence of 20^g/ml Con A for 24 hours. IFN activity was determined by means of inhibition of nucleic acid synthesis using LY cells and vesicular stomatitis virus. ICR mice (n=l) sensitized intravenously with 1 x107 BCGcells on day 0 were given ubenimex orally once daily for 4 days from day 10 to 13. On day 14, they were bled 2 hours after iv injection with 50^g LPS or 10T BCGcells. ICR mice (n= 3) were given ubenimex once daily for 10 days and injected intravenously 10^g poly-(IC) or 5 //g LPS 1 day after the last administration. They were bled 2 hours after the challenge. ICR mice (n=3) were sensitized intravenously with BCGcells 14 days before poly (IC) injection. They were bled 2 hours after the challenge.
dose of 1mg/kg was ineffective. Effect of ubenimex on the LPS-or poly (IC)-induced IFN production in normal mice was also tested.
ICR mice 0=3) were given ubenimex once a day daily for 10 days and injected with 5^g of LPS or 10 jug of poly (IC) intravenously 1 day FEB. 1988 after the last administration. Mice were bled 2 hours after the challenge.
In this case, oral administration of 1 mg/kg/day ubenimex markedly inhibited both of the IFN production induced by LPS and poly (IC) ( Ubenimex enhanced Con A-induced IFN production in spleen cell cultures and LPS-induced IFN production in mice sensitized with BCG. As reported previously6>7) , forphenicinol enhances both BCG-and LPS-induced IFN production in mice sensitized with BCG, but does not enhance Con A-induced IFN in spleen cell cultures. It has been shown that both low molecular weight immunomodifiers act on macrophages5»8),and ubenimex also acts on T cells8»9) but forphenicinol dose not5). This difference would be due to their specificity of binding to ceDs. The one of mechanisms of action of these low molecular immunomodifiers in modulating immune responses can be elucidated from these effects on cytokine production.
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